RxDoctor Payments Data

Sylvia Oats

Adult Health · Lafayette, LANPI 1194966622

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 30.0% of the total. Reporting peaked in 2022 at $1,045 and has fallen 98.2% since, to $19 in 2025.

$1,983in general payments, 2019–2025

Across 141 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$595
  • AbbVie$391
  • Takeda Pharmaceuticals U.S.A., Inc.$349
  • Bristol Myers Squibb$174
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$139
  • Pfizer$125
  • plus $210 from 9 others

What the payments were for

  • Food & beverage$1,86194%
  • Education$1226%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,983 in reported general payments places this provider in the 65th percentile of 203 adult health providers in Louisiana.

See all adult health providers in Louisiana →

Other adult health in Lafayette

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →